Why the study?
Does the combination of dihydroergotamine and heparin prevent postoperative deep-vein thrombosis more effectively than either agent alone in patients undergoing major abdominal surgery or hip replacement arthroplasty?
Does the combination of dihydroergotamine and heparin prevent postoperative deep-vein thrombosis more effectively than either agent alone in patients undergoing major abdominal surgery or hip replacement arthroplasty?
The combination of dihydroergotamine and heparin provides a synergistic effect, proving more effective than either agent alone for DVT prophylaxis after major surgery.
Answers are grounded in this paper and cite their sources.
Supports combined prophylaxis after major surgery; confirms synergistic benefit over monotherapy in RCT.
Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to investigate the efficacy of dihydroergotamine mesylate, heparin calcium, or a combination of dihydroergotamine with heparin in preventing postoperative deep-vein thrombosis (DVT). The diagnosis of DVT was established by an uptake test using fibrinogen labeled with iodine 125; in patients undergoing hip replacement, phlebography was also employed to confirm or refute the presence of isotopic thrombi. The data indicate that the combination of dihydroergotamine and heparin is more effective than heparin or dihydroergotamine alone in preventing DVT. (JAMA241:39-42, 1979)
No takes yet. Share an insight, caveat, or question.
V. V. Kakkar (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: